NEW YORK (GenomeWeb News) – Bruker has filed a shelf registration with the US Securities and Exchange Commission for the potential sale of up to 70 million shares of common stock, consisting of primary and secondary shares.
The firm said that under the offering, three shareholders from the Laukien family may sell up to 35 million secondary shares from time to time at prices and terms to be determined at the time of such an offering. Bruker also noted that its President and CEO, Frank Laukien, and two other Laukien shareholders are not among the family members that are registering shares for possible resale.
Bruker also may offer up to 35 million primary shares of its common stock under the registration statement. However, the firm said that it presently has no plans to offer any of the primary shares.